EW
Edwards Lifesciences Corp
NYSE · Healthcare · Medical - Devices · US
$88.26
+0.01%Next report
Analyst consensus
- Next report date
- Oct 29, 2026
- EPS estimate
- $0.73
- Revenue estimate
- $1.7B
Latest reported
- Last report date
- Jul 23, 2026
- EPS actual
- $0.78
- EPS estimate
- $0.74
- Revenue actual
- $1.7B
- Revenue estimate
- $1.7B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 3
- Avg surprise (4Q)
- +7.9%
- Revenue beats (12Q)
- 8
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $104
- PT range
- $95 – $110
- Analysts
- 9
8 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 23, 2026 | $0.74 | $0.78 | Beat 4.98% | $1.7B |
| Apr 23, 2026 | $0.73 | $0.78 | Beat 7.00% | $1.6B |
| Oct 30, 2025 | $0.60 | $0.67 | Beat 12.42% | $1.6B |
| Jul 24, 2025 | $0.62 | $0.67 | Beat 7.37% | $1.5B |
| Apr 23, 2025 | $0.60 | $0.64 | Beat 7.38% | $1.4B |
| Oct 24, 2024 | $0.67 | $0.67 | Beat 0.75% | $1.4B |
| Jul 24, 2024 | $0.69 | $0.70 | Beat 1.45% | $1.4B |
| Apr 25, 2024 | $0.64 | $0.66 | Beat 3.13% | $1.6B |
| Feb 6, 2024 | $0.64 | $0.64 | In line | $1.5B |
| Oct 25, 2023 | $0.59 | $0.59 | In line | $1.5B |
| Jul 26, 2023 | $0.65 | $0.66 | Beat 1.54% | $1.5B |
| Jan 31, 2023 | $0.61 | $0.64 | Beat 4.92% | $1.3B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 29, 2026